Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Clinical Director - Replacement

18 Mar 2020 07:22

RNS Number : 5875G
Medica Group PLC
18 March 2020
 

This announcement replaces RNS No 4950G Released on 18/03/2020 07:00.

 

18 March 2020

Medica Group Plc

 

Appointment of Clinical Director

 

 

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, is pleased to announce that Dr. Robert Lavis has been appointed to the newly created role of Clinical Director starting 1 June 2020. Dr. Lavis will report to Dr. Stephen Davies, the Company's Medical Director.

 

Dr. Lavis joins Medica from Gloucestershire Hospitals NHS Foundation Trust where he is currently a Consultant Radiologist and former Clinical Director. Dr. Lavis has extensive experience of clinical practice starting his career as a surgeon before entering radiology with a specialist focus on oncology.

 

Dr. Stephen Davies, Medical Director at Medica, said:

"I am delighted to have Robert join our growing team of clinical experts at Medica. With his background of working in the NHS, combined with his expertise in oncology reporting, Robert brings a highly relevant breadth and depth of experience that will help Medica to continue to drive quality and performance improvements and to expand the service offering to our clients and their patients."

 

Dr. Stuart Quin, Chief Executive Officer of Medica, added:

"Robert has had a longstanding relationship with Medica both as a customer and as a contracted reporter. His insight and expertise will help us to continue to enhance the service we offer. I particularly look forward to working with Robert to drive strategic projects within the Company, such as the deployment of artificial intelligence and continual improvements in our quality management systems."

 

Commenting on his appointment, Dr. Robert Lavis said:

"I am excited to be joining Medica as Clinical Director. The creation of this new role underlines Medica's commitment to continually invest in quality, innovation and service development. I know Medica and teleradiology well from my time within the NHS and as a contracted reporter for many years. I look forward to applying my experience as part of the management team to drive future growth and quality improvements."

 

For further information, please contact:

 

Medica Group

Stuart Quin, Chief Executive Officer

 

+44 (0)33 33 111 222

 

 

FTI Consulting

Victoria Foster Mitchell

Robert Winder

+44 (0)20 3727 1000

 

About Medica Group PLC

 

Medica is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

 

Medica has developed a bespoke, secure IT platform that provides market-leading linkage between a hospital's radiology information system (RIS) and consultant radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKFBDOBKKQND
Date   Source Headline
6th Jul 20233:29 pmRNSForm 8.3 - Medica Group plc
6th Jul 20233:25 pmBUSForm 8.3 - Medica Group plc
6th Jul 20233:00 pmRNSForm 8.3 - Medica Group PLC
6th Jul 20231:28 pmRNSHolding(s) in Company
6th Jul 202310:26 amGNWRule 8.3 - Medica Group Plc
6th Jul 202310:01 amRNSScheme of Arrangement becomes Effective
6th Jul 20239:32 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
6th Jul 20239:18 amRNSForm 8.5 (EPT/RI) - Medica Group Plc
5th Jul 20233:39 pmRNSDirector/PDMR Shareholding
5th Jul 20233:29 pmRNSForm 8.3 - Medica Group plc
5th Jul 202310:32 amGNWRule 8.3 - Medica Group Plc
5th Jul 20239:13 amRNSForm 8.5 (EPT/RI) - Medica Group Plc
5th Jul 20238:49 amRNSForm 8.5 (EPT/RI)
5th Jul 20237:52 amRNSForm 8.3 - Medica Group PLC
4th Jul 20233:30 pmRNSForm 8.3 - MGP LN
4th Jul 20233:25 pmBUSForm 8.3 - Medica Group plc
4th Jul 20233:00 pmRNSForm 8.3 - Medica Group PLC
4th Jul 20232:57 pmRNSForm 8.3 - MEDICA GROUP PLC
4th Jul 20232:53 pmPRNForm 8.3 - Medica Group Plc
4th Jul 202312:37 pmRNSIssue of Equity and Rule 2.9 Announcement
4th Jul 202312:18 pmRNSCourt Sanction of Scheme of Arrangement
4th Jul 202312:17 pmRNSForm 8.3 - Medica Group PLC
4th Jul 202310:58 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
4th Jul 20239:47 amRNSForm 8.5 (EPT/RI) - Medica Group Plc
4th Jul 20239:11 amRNSForm 8.5 (EPT/RI)
3rd Jul 20233:30 pmRNSForm 8.3 - MGP LN
3rd Jul 20233:25 pmBUSForm 8.3 - Medica Group plc
3rd Jul 20233:01 pmPRNForm 8.3 - Medica Group Plc
3rd Jul 20232:39 pmPRNForm 8.3 - Medica Group Plc
3rd Jul 202311:04 amRNSForm 8.3 - Medica Group PLC
3rd Jul 20239:32 amRNSHolding(s) in Company
3rd Jul 20239:16 amRNSForm 8.5 (EPT/RI)
3rd Jul 20237:00 amRNSForm 8.3 - Medica Group PLC
30th Jun 20233:25 pmBUSForm 8.3 - Medica Group plc
30th Jun 20233:08 pmRNSForm 8.3 - Medica Group PLC
30th Jun 20232:38 pmPRNForm 8.3 - Medica Group Plc
30th Jun 202312:59 pmPRNForm 8.3 - Medica Group Plc
30th Jun 202311:53 amRNSResult of Annual General Meeting
30th Jun 20237:00 amRNSAGM Statement
29th Jun 20235:30 pmRNSMedica Group
29th Jun 20233:25 pmBUSForm 8.3 - Medica Group plc
29th Jun 20233:21 pmRNSHolding(s) in Company
29th Jun 20233:10 pmRNSForm 8.3 - Medica Group PLC
29th Jun 20232:47 pmPRNForm 8.3 - Medica Group Plc
29th Jun 20239:46 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
29th Jun 20239:10 amRNSForm 8.5 (EPT/RI)
28th Jun 20233:42 pmBUSForm 8.3 - Medica Group plc
28th Jun 20233:03 pmRNSForm 8.3 - MEDICA GROUP PLC
28th Jun 20231:30 pmPRNForm 8.3 - Medica Group Plc
28th Jun 202311:16 amRNSForm 8.3 - Medica Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.